<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>1471-2156-6-10.fm</title>
<meta name="Author" content="csproduction"/>
<meta name="Creator" content="FrameMaker 7.0"/>
<meta name="Producer" content="Acrobat Distiller 5.0.5 (Windows)"/>
<meta name="CreationDate" content=""/>
</head>
<body>
<pre>
BMC Genetics

BioMed Central

Open Access

Research article

A novel replication-independent histone H2a gene in mouse
Hiromi Nishida*, Takahiro Suzuki, Yasuhiro Tomaru and
Yoshihide Hayashizaki
Address: Laboratory for Genome Exploration Research Group, RIKEN Genomic Sciences Center (GSC), RIKEN Yokohama Institute, 1-7-22
Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan
Email: Hiromi Nishida* - hnishida@gsc.riken.jp; Takahiro Suzuki - t-suzuki@gsc.riken.jp; Yasuhiro Tomaru - tomaru@gsc.riken.jp;
Yoshihide Hayashizaki - yosihide@gsc.riken.jp
* Corresponding author

Published: 19 February 2005
BMC Genetics 2005, 6:10

doi:10.1186/1471-2156-6-10

Received: 07 October 2004
Accepted: 19 February 2005

This article is available from: http://www.biomedcentral.com/1471-2156/6/10
Â© 2005 Nishida et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract
Background: An uncharacterized histone H2a-coding transcript (E130307C13) has been cloned
from a mouse full-length cDNA library. This transcript is encoded on chromosome 6,
approximately 4 kb upstream of a histone H4 gene, Hist4h4. The proteins encoded by this
transcript and the human H2afj mRNA isoform-2 have the highest amino acid similarity. In this
paper, we characterize it from the expression pattern given by quantitative RT-PCR.
Results: Quantitative RT-PCR indicated that the gene that encodes E130307C13 (E130307C13)
is regulated in a replication-independent manner, and therefore it is H2afj. Certainly, H2afj
transcript lacks a stem-loop structure at the 3'-UTR but contains a poly (A) signal. In addition, its
promoter region has a different structure from those of the replication-dependent histone H2a
genes.
Conclusion: The bioinformatics imply that E130307C13 is a replication-independent H2a gene. In
addition, quantitative RT-PCR analysis shows that it is replication-independent. Thus, it is H2afj, a
novel replication-independent H2a gene in mouse.

Background
Replication of the eukaryotic chromosomes requires the
synthesis of histones to package the newly replicated DNA
into chromatin. Control of the level of histone mRNA
accounts for much of the control of histone protein synthesis [1]. Mouse has 18 replication-dependent histone
H2a genes [2]. Among these 18 genes, 13 genes are
located in the Hist1 cluster on chromosome 13, 4 in the
Hist2 cluster on chromosome 3 and 1 in the Hist3 cluster
on chromosome 11 [2]. The histone mRNAs that are cellcycle-regulated increase 35-fold as cells progress from
mitosis through G1-phase and into S-phase [3]. The promoters of histone genes contain CCAAT and TATA boxes

[4]. The replication-dependent histone H2a genes lack
introns and a poly (A) signal. They have a conserved stemloop structure (5'-GGCTCTTTTCAGAGCC-3') at the 3'UTR, which plays an important role in mRNA processing
and stability [5-7].
Mouse also has two replication-independent histone H2a
genes, H2afx on chromosome 9 and H2afz chromosome
3. These two genes encode polyadenylated mRNAs. H2afx
mRNA has both a polyadenylated tail and a stem-loop
structure [8]. Mouse replication-dependent histone H2a
mRNAs and H2afx mRNA have a nuclear export element
(5'-ACAACAAGAAGACGCGCATCAT-3') in the proteinPage 1 of 7
(page number not for citation purposes)

BMC Genetics 2005, 6:10

Hist1h2ab(M)
Hist1h2af(M)
HIST1H2AD(H)
43
Hist1h2ah(M)
Hist1h2ab 2ac 2ad 2ae 2ag 2ai 2an 2ao(M)
52 Hist1h2ak(M)
HIST1H2AB 2AE(H)
HIST1H2AG 2AI 2AK 2AL 2AM(H)
50
HIST1H2AH(H)
44
HIST1H2AJ(H)
58
HIST3H2A(H)
43
63 Hist3h2a(M)
HIST1H2AC(H)
HIST2H2AA(H)
23
59 Hist2h2aa1 2aa2(M)
79 HIST2H2AC(H)
Hist2h2ab 2ac(M)
37
45 HIST2H2AB(H)
69 similar Hist2h2ac(M)
99 H2AX(H)
61
H2afx(M)
H2AFJ isoform2(H)
12
99
92 E130307C13(M)
HIST1H2AA(H)
Hist1h2aa(M)
H2afz variant(M)
H2AFV(H)
similar H2afz(M)
71
69 H2AFZ(H)
38 H2afz(M)
similar H2AFZ(H)
22
0.05

Figure 1
from human relationships among 44 related proteins
Phylogenetic and mouse histone H2a amino acids sequences
Phylogenetic relationships among 44 amino acids sequences
from human and mouse histone H2a related proteins. The
bar indicates 5% difference of sequence. The numbers at the
branches indicate percentage of 1000 bootstrap analyses. (H)
and (M) indicate the human sequence and mouse sequence,
respectively.

coding region that functions to export the mRNA from the
nucleus to the cytoplasm [9].
An uncharacterized histone H2a-coding transcript
(E130307C13, FANTOM clone ID; NM_177688,
Genebank accession number) has been cloned from a
mouse full-length cDNA library. E130307C13 lies on
chromosome 6, approximately 4 kb upstream of Hist4h4.
In this paper, we characterize it from the expression pattern given by quantitative RT-PCR. In addition to this, we
compared the structure with the sequences deposited in
the international DNA/protein database.

Results and discussion
Comparison of the putative amino acid sequence encoded
by E130307C13 with the amino acid sequences deposited
in the international DNA/protein database showed that it
has the highest similarity to that encoded by human H2afj
mRNA isoform-2 (NM_177925, Genebank accession
number; Figs. 1, 2). Human has two isoforms of H2afj
[10,11]. Isoform-1 (NM_018267, Genebank accession
number) is produced after splicing of two introns; isoform-2 does not need intron splicing for maturation.

http://www.biomedcentral.com/1471-2156/6/10

Interestingly, H2afj also lies near a histone H4 gene, on
human chromosome 12. According to the nomenclature
of histone genes [2], if E130307C13 is regulated in a replication-dependent manner, it is recognized as Hist4h2a.
But if it is regulated in a replication-independent manner,
it is recognized as H2afj.
Each product of the quantitative RT-PCR gave a single
band on the agarose gel of the expected size (Fig. 3).
Observation using the quantitative RT-PCR showed that
the expression pattern of E130307C13 is typical of replication-independent histone gene (Table 1, Fig. 3). The
expression pattern of E130307C13 is more similar to that
of the replication-independent H2afz than to that of the
replication-dependent Hist2h2aa2. The expression of
Hist2h2aa2 increased along with cell cycle progression
from the beginning of S-phase (0 h), peaked at 2 h, and
then decreased (Fig. 3). On the other hand, E130307C13
and H2afz were expressed constantly (Fig. 3). These results
suggest that E130307C13 is a replication-independent histone H2a gene in mouse. According to the nomenclature
of histone genes [2], E130307C13 is recognized not as
Hist4h2a but as H2afj.
Upstream of the 5'-end of E130307C13, no TATA box was
found. In addition, the first CCAAT box lies 230 bases
upstream of the translation start codon (Fig. 4). The other
replication-dependent H2a genes have the first CCAAT
and TATA boxes within 100 bases upstream of the translation start codon (Fig. 4). The replication-independent
genes H2afx and H2afz also have a TATA box (Fig. 4).
Thus, histone H2a genes have a TATA box in the promoters, except for E130307C13. Interestingly, the promoter of
H2afz lacks CCAAT box but includes TATA box, on the
other hand, that of E130307C13 lacks TATA box but
includes CCAAT box (Fig. 4).
In addition, the 3'-UTR of the E130307C13 mRNA does
not include the conserved stem-loop structure (Fig. 5). But
the E130307C13 mRNA has two poly (A) signals at the
middle and near the 3'-end. It indicates that the
E130307C13 gives rise to two differentially polyadenylated mRNA transcripts. Considering the position at the
3'-UTR, it has a possibility that the poly (A) signal near the
3'-end is functional. Except for the pseudogene Hist1h2aj,
the replication-dependent H2a mRNAs have the conserved stem-loop structure at the 3'-UTR. H2afx gives rise
to a cell-cycle-regulated mRNA ending in the stem-loop
when it is transcribed during S-phase, and a polyadenylated mRNA that is present in G1-phase cells [2,8].
H2afz mRNA lacks the stem-loop structure and has poly
(A) signals. H2afz contains four introns in the proteincoding region and needs a splicing mechanism to produce
the mature mRNA. Interestingly, E130307C13 lacks
introns. Comparing the transcript structure of

Page 2 of 7
(page number not for citation purposes)

BMC Genetics 2005, 6:10

http://www.biomedcentral.com/1471-2156/6/10

H2AX(H)
H2afx(M)
H2AFJ_isoform2(H)
E130307C13(M)
HIST2H2AC(H)
Hist2h2ab_2ac(M)
Hist1h2ak(M)
Hist1h2ab(M)
HIST1H2AB_2AE(H)
Hist1h2ah(M)
Hist1h2ab_2ac_2ad_2ae_2ag_2ai_2a
Hist1h2af(M)
HIST1H2AD(H)
HIST3H2A(H)
Hist3h2a(M)
HIST1H2AC(H)
HIST1H2AG_2AI_2AK_2AL_2AM(H)
HIST1H2AH(H)
HIST1H2AJ(H)
HIST2H2AA(H)
Hist2h2aa1_2aa2(M)
HIST2H2AB(H)
similar_Hist2h2ac(M)
HIST1H2AA(H)
Hist1h2aa(M)
H2AFZ(H)
H2afz(M)
similar_H2AFZ(H)
similar_H2afz(M)
H2AFV(H)
H2afz_variant(M)
H2AX(H)
H2afx(M)
H2AFJ_isoform2(H)
E130307C13(M)
HIST2H2AC(H)
Hist2h2ab_2ac(M)
Hist1h2ak(M)
Hist1h2ab(M)
HIST1H2AB_2AE(H)
Hist1h2ah(M)
Hist1h2ab_2ac_2ad_2ae_2ag_2ai_2a
Hist1h2af(M)
HIST1H2AD(H)
HIST3H2A(H)
Hist3h2a(M)
HIST1H2AC(H)
HIST1H2AG_2AI_2AK_2AL_2AM(H)
HIST1H2AH(H)
HIST1H2AJ(H)
HIST2H2AA(H)
Hist2h2aa1_2aa2(M)
HIST2H2AB(H)
similar_Hist2h2ac(M)
HIST1H2AA(H)
Hist1h2aa(M)
H2AFZ(H)
H2afz(M)
similar_H2AFZ(H)
similar_H2afz(M)
H2AFV(H)
H2afz_variant(M)

-----MSGRG
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----.....
-----...PT
---MAGGKA.
---MAGGKA.
---MTGGKA.
---MAGGKA.
---MAGGKA.
MYVCAACTYS
KKTRIIPRHL
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
.....T....
.VK..T....
.VK..T....
.VK.STTG..
.VKC.T....
.VK..T....
.VK..T....

KTGGKARAKA
..........
.Q...V....
.Q...V....
.Q........
.Q........
.Q........
.Q.C......
.Q........
.Q........
.Q........
.Q........
.Q........
.Q........
.Q........
.Q........
.Q........
.Q........
.Q........
.Q........
.Q........
.Q........
.Q........
.Q.......S
.R.......V
.DS...KT..
.DS...KT..
.DS...KT..
.DS...KT..
.DS...K...
AR..QT.ESD
QLAIRNDEEL
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
...V......
...V......
..........
..........
.....G....
.....G....
.....G....
.....G....
.....G....
.....G....

KSRSSRAGLQ
..........
..........
..........
..........
..........
.T........
.T........
.T........
.T........
.T........
.T........
.T........
..........
..........
..........
.T........
.T........
.T........
..........
..........
..........
..........
..........
..........
V...Q.....
V...Q.....
V..CQ.....
V...Q....X
V...Q.....
ILELDSHMCH
NKLLGGVTIA
..........
.....K....
.....R....
.....K....
.....K....
.....R....
.....R....
.....R....
.....R....
.....R....
.....R....
.....K....
.....R....
.....R....
.....R....
.....K....
.....K....
.....K....
.....K....
.....K....
..........
..........
..........
.....R....
DS.IK-A...
DS.IK-A...
DS.IK-A...
DS.IK-A...
DS.IK-A...
DS.IK-A...

FPVGRVHRLL
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
.....I....
..........
.....I..H.
.....I..H.
.....I.LH.
..L.CI..H.
.....I..H.
.....I..H.
QGGVLPNIQA
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
G...I.H.HK
G...I.H.HK
G...I.H.HK
G.C.I.H.HK
G...I.H.HK
G...I.H.HK

R-KGHYAERV
.-........
.-..N.....
.-..N.....
.-..N.....
.-..N.....
.-..N.S...
.-..N.S...
.-..N.S...
.-..N.S...
.-..N.S...
.-..N.S...
.-..N.S...
.-..N.S...
.-..N.S...
.-..N.....
.-..N.....
.-..N.....
.-..N.....
.-..N.....
.-..N.....
.-..N.....
.-..N.....
.-..N....I
.-Q.N..Q.I
KSRTTSHG..
KSRTTSHG..
KSRTTNHG..
KSRTTSHG..
KTRTTSHG..
KTRTTSHG..
VLLPKKTSAT
......S...
.......ESQ
.......ESQ
.......ESH
.......ESH
.......ETH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
.......ESH
S.IG..GQQK
S.IG..GQQK
S.TG..GQQK
S.IG..GQQK
S.IG..GQQK
S.IG..GQQK

GAGAPVYLAA
..........
..........
..........
.......M..
.......M..
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
.......M..
.......M..
..........
.......M..
..........
..........
..T.A..S..
..T.A..S..
..T.A..S..
..T.A..S..
..T.A..S..
..T.A..S..
VGPKAPSGGK
......AV..
KTKSK----KVKSK----KAKSK----KAKSK----HKA.GK---HKA.GK---HKA.GK---HKA.-----HKA.GK---HK..GK---HKA.GK---HKA.GK---HKA.GK---HKA.GK---HKA.GK---HKA.-----HKT.-----HKA.GK---HKA.GK---KPG.NK---KPG.NK---HHKAQSK--KSQTK----TV-------TV-------TV-------TI-------TA-------TA--------

VLEYLTAEIL
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
........V.
I.......V.
I.......V.
I.K.....V.
I..D......
I.......V.
I.......V.
KATQASQEY
..S......
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ELAGNAARDN
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
..........
......S...
..........
......SK.L
......SK.L
......SK.L
......SK.L
......SK.L
......SK.L

Figure 2
Alignment of the human and mouse histone H2a proteins in Fig. 1
Alignment of the human and mouse histone H2a proteins in Fig. 1.

Table 1: CT values, âCT, and ââCT
Time GAPD E13030 âCT ââCT Expression E13030 âCT ââCT Expression Hist2h âCt ââCT Expression Hist2h âCT ââCT Expression
(h)
H 7C13_
7C13_
2aa_1
2aa_2
1
2
0
1
2
3
4
5
6
7
8
9
10
11

14.4
14.4
14.4
14.3
14.4
14.4
14.1
14.2
14.3
14.3
14.2
14.3

19.1
19
18.9
18.8
19.2
19.2
19.8
19.7
19.2
19.3
19.1
19.8

4.65
0
4.64 -0.01
4.54 -0.11
4.5 -0.15
4.78 0.13
4.82 0.17
5.69 1.04
5.45
0.8
4.87 0.22
5.03 0.38
4.83 0.18
5.5 0.85

1
1.01
1.08
1.11
0.91
0.89
0.49
0.57
0.86
0.77
0.88
0.55

20
20.1
19.7
19.7
19.9
20
20.4
20.3
20.1
20
19.8
20.2

5.61
5.71
5.32
5.4
5.49
5.61
6.33
6.11
5.71
5.76
5.58
5.87

0
0.1
-0.29
-0.21
-0.12
0
0.72
0.5
0.1
0.15
-0.03
0.26

1
0.93
1.22
1.16
1.09
1
0.61
0.71
0.93
0.9
1.02
0.84

18.1
17.5
16.8
16.8
17.2
17.1
18.4
17.6
17.6
17.8
17.8
18.3

3.63
3.1
2.42
2.48
2.79
2.66
4.29
3.35
3.3
3.54
3.6
4

0
-0.53
-1.21
-1.15
-0.84
-0.97
0.66
-0.28
-0.33
-0.09
-0.03
0.37

1
1.44
2.31
2.22
1.79
1.96
0.63
1.21
1.26
1.06
1.02
0.77

19.3
19.2
18.3
18.3
18.3
18.6
19.9
19
19.2
19.3
18.7
19.2

4.9
4.79
3.92
3.92
3.93
4.17
5.8
4.83
4.81
5.01
4.5
4.91

0
-0.11
-0.98
-0.98
-0.97
-0.73
0.9
-0.07
-0.09
0.11
-0.4
0.01

1
1.08
1.97
1.97
1.96
1.66
0.54
1.05
1.06
0.93
1.32
0.99

H2afz âCT ââCT Expression

16.8
16.6
16.7
16.8
16.8
16.8
16.8
16.9
16.9
16.6
16.6
16.2

2.35
2.26
2.33
2.46
2.43
2.42
2.71
2.7
2.55
2.34
2.4
1.94

0
-0.09
-0.02
0.11
0.08
0.07
0.36
0.35
0.2
-0.01
0.05
-0.41

1
1.06
1.01
0.93
0.95
0.95
0.78
0.78
0.87
1.01
0.97
1.33

Page 3 of 7
(page number not for citation purposes)

BMC Genetics 2005, 6:10

http://www.biomedcentral.com/1471-2156/6/10

1

2

3

4

3

4

5

6

200 bp
100 bp

2.5

2

1.5

1

0.5

0
0

1

2

5

6

7

E130307C13_1

E130307C13_2

Hist2h2aa2_2

8

9

10

11

Hist2h2aa2_1

H2afz

Figure
RT-PCR3products on agarose gel and expression patterns
RT-PCR products on agarose gel and expression patterns. Lanes 1, 100 bp ladder; 2, RT-PCR product amplified with
E130307C13 primer set 2; 3, that with E130307C13 primer set 1; 4, that with Hist2h2aa2 primer set 1; 5, that with Hist2h2aa2
primer set 2; 6, that with H2afz primer set.

Page 4 of 7
(page number not for citation purposes)

BMC Genetics 2005, 6:10

Hist1h2aa,
Hist1h2ab,
Hist1h2ac,
Hist1h2ad,
Hist1h2ae,
Hist1h2af,
Hist1h2ag,
Hist1h2ah,
Hist1h2ai,
Hist1h2aj,
Hist1h2ak,
Hist1h2an,
Hist1h2ao,
Hist2h2aa1,
Hist2h2aa2,
Hist2h2ab,
Hist2h2ac,
Hist3h2a,
H2afx,
H2afz,
E130307C13,

http://www.biomedcentral.com/1471-2156/6/10

5â-CCAATCAGGTGTTGAGCATAAGCTGCCATTAGACTATAAATA-(49)-ATG-3â
5â-CCAATGGGAGAAACACAAACAGAATACCTCCAGTTAGTATAAAT-(79)-ATG-3â
5â-CCAATCAAGTAGTAGCGTTTACTACCCAGGAACCTACTATAAAA-(67)-ATG-3â
5â-CCAATGGCATAGGTCCTTTTTCGCGCCCAGCGAATAATATAAA-(54)-ATG-3â
5â-CCAATCACACATCAGCTTTTCCACTTCCATGTACGAGTATAA-(76)-ATG-3â
5â-CCAACGAGATCACTCCGTTTTCGCGCCAGAAGTTGAGTATTA-(60)-ATG-3â
5â-CCAATCCCGAACGTTCCTTTTCGCGCCCAGAGAAAACTATAA-(60)-ATG-3â
5â-CCAATGACGGGCCTCCTTTTTCGCGCCCTGGCTTGACTATAAAAA-(68)-ATG-3â
5â-CCAATGAAATCTCTCCGTTTTCGCGTCCAGCCTTGACTATATATA-(53)-ATG-3â
5â-CCAATGCTACGTCTTCATTTTTAGCGCCATTCAGTCAATAA-3â
5â-CCAATGAAATTCCTACTTTTTCATGCCCTGCATTGACTATAAA-(58)-ATG-3â
5â-CCAATCGCGTAGGCTCTTTTTCGCGCTTGGAGAATCCTATAAA-(57)-ATG-3â
5â-CCAATCGCATAGGCCCTTTTTTGCGCCCAGAGAAAACTATAA-(58)-ATG-3â
5â-CCAATGAGAGCGTCGGGCGGACAATCGGGTCTGCGTCTATAAAA-(66)-ATG-3â
5â-CCAATGAGAGCGTCGGGCGGACAATCGGGTCTGCGTCTATAAAA-(66)-ATG-3â
5â-CCAATGAAAAGCTCCCTCCTCACCCCACCCCTAGGAGCGCCTATAAA-(72)-ATG-3â
5â-CCAATGAAAAGCTCCCTCCTCACCCCACCCCTAGGAGCGCCTATAAA-(72)-ATG-3â
5â-CCAATAGGAAGGTGCAGTCTAGCCTCCCTCCTGATCATATATATAA-(77)-ATG-3â
5â-CCAATCAGGAGGAAGCGGGGGCGTGTCCAGGGAGTTTATAA-(93)-ATG-3â
5â-ATTGGTGGGCCGAACCGGCCGAGTTCCCGGATGAGGGAACATTCTGCAGTATAAA-(130)-ATG-3â
5â-CCAATCCCAACAAGTTTGAGGATGCCTGTGAACTATGTAAA-(195)-ATG-3â

Figure 4 between CCAAT and TATA boxes upstream of the histone H2a and E130307C13 coding regions
Sequences
Sequences between CCAAT and TATA boxes upstream of the histone H2a and E130307C13 coding regions. Underlines indicate CCAAT and TATA boxes. The ATGs located at the 3'-end indicate translation start codon. Numbers in parentheses represent numbers of bases not shown. The Hist1h2aj is a pseudogene, lacking a start codon.

E130307C13 with those of the other histone H2a genes
suggests that E130307C13 has replication-independent
characteristics.

Conclusion
The bioinformatics imply that E130307C13 is a replication-independent H2a gene. In addition, quantitative RTPCR analysis shows that it is replication-independent.
Thus, it is H2afj, a novel replication-independent H2a
gene in mouse.

Cell cycle synchronization
The cell cycle of Hepa 1â6 cells was synchronized at the
end of G1-phase by the addition of thymidine-hydroxyurea. The cell cycle arrest was released by washing out the
thymidine-hydroxyurea, then the cells were harvested at
intervals of 1 h from 0 h to 11 h.
RNA extraction
Total RNA was extracted by using the RNeasy mini kit
(Qiagen) according to the manual for the cell line. After
that, each sample was treated with DNase I.

Methods
Phylogenetic tree construction
Multiple alignment of 44 amino acids sequences of histone H2a related proteins from human and mouse was
created using the CLUSTAL W [12] on the DNA Databank
of Japan. The phylogenetic tree by the neighbor-joining
method with 1000 bootstrap analyses was constructed
based on the multiple alignment using MEGA version 2.1
[13].

cDNA synthesis
RNA (approximately 0.5 Âµg) and random hexamer primers were heated to 70Â°C for 10 min, followed by cooling
on ice for 5 min. The cDNA was synthesized using Superscript III First Strand buffer (Invitrogen) according to the
manual. The reverse transcriptase was inactivated by a 15min incubation at 70Â°C.
Quantitative PCR
The following primers were used: 5'-AACTGTAGCCCGGCCCG-3' and 5'-TTCGTCTGTTTGCGCTTT-3' (primer

Page 5 of 7
(page number not for citation purposes)

BMC Genetics 2005, 6:10

http://www.biomedcentral.com/1471-2156/6/10

Nuclear export element
Hist1h2aa,
Hist1h2ab,
Hist1h2ac,
Hist1h2ad,
Hist1h2ae,
Hist1h2af,
Hist1h2ag,
Hist1h2ah,
Hist1h2ai,
Hist1h2aj,
Hist1h2ak,
Hist1h2an,
Hist1h2ao,
Hist2h2aa1,
Hist2h2aa2,
Hist2h2ab,
Hist2h2ac,
Hist3h2a,
H2afx,
H2afz,
E130307C13,

Stem-loop structure

5â-ATG-(214)-ACAACAAGAAGACGCGCATTAC-(148)-TGA-(39)-GGCTCTTTTCAGAGCC-3â
5â-ATG-(214)-...................C.T-(151)-TAA-(46)-................-3â
5â-ATG-(214)-...................C.T-(151)-TAA-(32)-................-3â
5â-ATG-(214)-...................C.T-(151)-TAA-(31)-................-3â
5â-ATG-(214)-...................C.T-(151)-TAA-(32)-................-3â
5â-ATG-(214)-...................C.T-(151)-TAA-(55)-................-3â
5â-ATG-(214)-...................C.T-(151)-TAA-(36)-................-3â
5â-ATG-(214)-...................C.T-(145)-TGA-(23)-................-3â
5â-ATG-(214)-...................C.T-(151)-TGA-(24)-................-3â
(LACK)
...................C.T
(LACK)
(LACK)
5â-ATG-(214)-.....................T-(151)-TGA-(37)-................-3â
5â-ATG-(214)-...................C.T-(151)-TAA-(32)-...............T-3â
5â-ATG-(214)-...................C.T-(151)-TAA-(38)-................-3â
5â-ATG-(214)-...................C.T-(151)-TGA-(58)-................-3â
5â-ATG-(214)-...................C.T-(151)-TGA-(58)-................-3â
5â-ATG-(214)-...................C.T-(148)-TGA-(21)-.........T......-3â
5â-ATG-(214)-...................C.T-(148)-TGA-(21)-.........T......-3â
5â-ATG-(214)-....T...........A..C.T-(151)-TGA-(41)-................-3â
5â-ATG-(214)-...................C.T-(190)-TGA-(46)-...C.....A..G...-3â
(LACK)
(LACK)
5â-ATG-(214)-...................C.T-(148)-TGA
(LACK)

Figure 5
Alignment of nuclear export elements and stem-loop structures
Alignment of nuclear export elements and stem-loop structures. ATG indicates translation start codon. TAA or TGA indicates
translation stop codon.

set 1, product size 100 bp) and 5'-CAACAAGCTGCTGGGCAAA-3' and 5'-TCGCCTTATGGTGGCTCTCC-3'
(primer set 2, product size 101 bp) for transcripts of
Hist2h2aa2; 5'-ACTCCGGAAAGGCCAAGACA-3' and 5'GTTGTCCTAGATTTCAGGTG-3' for H2afz, product size
100 bp; 5'-CGTCCTGCCCAATATCCAG-3' and 5'-TCTGCACCCGTCTGTCG-3' (primer set 1, product size 90 bp)
and 5'-AAGCAGGGCGGTAAGGTG-3' and 5'-TCCGCGTAGTTGCCCTTC-3' (primer set 2, product size 110 bp)
for E130307C13; and 5'-TGTGTCCGTCGTGGATCTGA-3'
and 5'-CCTGCTTCACCACCTTCTTGA-3' for GAPDH
(glyceraldehyde-3-phosphate dehydrogenase), product
size 76 bp. Quantification of GAPDH mRNA was used as
a control for data normalization. PCR amplification was
performed on an ABI PRISM 7700 Sequence Detection
System (Applied Biosystems). The PCR conditions were
an initial step of 30 s at 95Â°C, followed by 40 cycles of 5
s at 95Â°C and 30 s at 60Â°C. The SYBR premix Ex Taq
(Takara) was used according to the manual. Expression
was assessed by evaluating threshold cycle (CT) values.
The relative amount of expressed RNA was calculated
using Livak and Schmittgen's method [14].

Authors' contributions
HN designed this study, carried out the molecular biological studies, and the molecular evolutionary studies. TS
and YT carried out synchronization of cells and quantitative RT-PCR. YH participated in the design of this study.

Acknowledgements
We thank the two anonymous reviewers for their helpful comments. This
work was supported in part by a Research Grant for the RIKEN Genome
Exploration Research Project, a Research Grant for Advanced and Innovational Research Program in Life Science, and a Research Grant for the
Genome Network Project from the Ministry of Education, Culture, Sports,
Science and Technology (MEXT) of the Japanese Government, and in part
by a Research Grant for CREST of Japan Science and Technology Corporation to Y.H., and supported in part by grant 15770055 from the MEXT to
H.N.

References
1.
2.
3.

Marzluff WF, Duronio RJ: Histone mRNA expression: multiple
levels of cell cycle regulation and important developmental
consequences. Curr Opin Cell Biol 2002, 14:692-699.
Marzluff WF, Gongidi P, Woods KR, Jin J, Maltais LJ: The human and
mouse replication-dependent histone genes. Genomics 2002,
80:487-498.
Harris ME, BÃ¶hni R, Schneiderman MH, Ramamurthy L, SchÃ¼mperli D,
Marzluff WF: Regulation of histone mRNA in the unperturbed
cell cycle: evidence suggesting control at two posttranscriptional steps. Mol Cell Biol 1991, 11:2416-2424.

Page 6 of 7
(page number not for citation purposes)

BMC Genetics 2005, 6:10

4.
5.
6.
7.

8.

9.
10.

11.

12.

13.
14.

Osley MA: The regulation of histone synthesis in the cell cycle.
Annu Rev Biochem 1991, 60:827-861.
Dominski Z, Marzluff WF: Formation of the 3' end of histone
mRNA. Gene 1999, 239:1-14.
Graves RA, Pandey NB, Chodchoy N, Marzluff WF: Translation is
required for regulation of histone mRNA degradation. Cell
1987, 48:615-626.
Lanzotti DJ, Kaygum H, Yang X, Duronin RJ, Marzluff WF: Developmental control of histone mRNA and dSLBP synthesis during Drosophila embryogenesis and the role of dSLBP in
histone mRNA 3' processing in vivo. Mol Cell Biol 2002,
22:2267-2282.
Mannironi C, Bonner WM, Hatch CL: H2A.X. a histone isoprotein with a conserved C-terminal sequence, is encoded by a
novel mRNA with both DNA replication type and polyA 3'
processing signals. Nucleic Acids Res 1989, 17:9113-9126.
Huang Y, Steitz JA: Splicing factors SRp20 and 9G8 promote
the nucleocytoplasmic export of mRNA. Mol Cell 2001,
7:899-905.
Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M,
Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito
K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda
T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku
Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T,
Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato
K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H,
Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S,
Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta
T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO,
Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N,
Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y,
Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H,
Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A,
Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe
T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K,
Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro
H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao
M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y,
Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K,
Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M,
Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, MizushimaSugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K,
Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K,
Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete
sequencing and characterization of 21,243 full-length human
cDNAs. Nat Genet 2004, 36:40-45.
Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, Zeeberg B,
Buetow KH, Schaefer CF, Bhat NK, Hopkins RF, Jordan H, Moore T,
Max SI, Wang J, Hsieh F, Diatchenko L, Marusina K, Farmer AA, Rubin
GM, Hong L, Stapleton M, Soares MB, Bonaldo MF, Casavant TL,
Scheetz TE, Brownstein MJ, Usdin TB, Toshiyuki S, Carninci P, Prange
C, Raha SS, Loquellano NA, Peters GJ, Abramson RD, Mullahy SJ,
Bosak SA, McEwan PJ, McKernan KJ, Malek JA, Gunaratne PH, Richards S, Worley KC, Hale S, Garcia AM, Gay LJ, Hulyk SW, Villalon
DK, Muzny DM, Sodergren EJ, Lu X, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madan A,
Young AC, Shevchenko Y, Bouffard GG, Blakesley RW, Touchman
JW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J,
Myers RM, Butterfield YS, Krzywinski MI, Skalska U, Smailus DE,
Schnerch A, Schein JE, Jones SJ, Marra MA: Generation and initial
analysis of more than 15,000 full-length human and mouse
cDNA sequences. Proc Natl Acad Sci USA 2002, 99:16899-16903.
Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving
the sensitivity of progressive multiple sequence alignment
though sequence weighting, position-specific gap penalties
and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
Kumar S, Tamura K, Jakobsen IB, Nei M: MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 2001,
17:1244-1245.
Livak KJ, Schmittgen TD: Analysis of relative gene expression
data using real-time quantitative PCR and the 2-ââCT
method. Methods 2001, 25:402-408.

http://www.biomedcentral.com/1471-2156/6/10

Publish with Bio Med Central and every
scientist can read your work free of charge
"BioMed Central will be the most significant development for
disseminating the results of biomedical researc h in our lifetime."
Sir Paul Nurse, Cancer Research UK

Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours â you keep the copyright

BioMedcentral

Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp

Page 7 of 7
(page number not for citation purposes)

</pre>
</body>
</html>
